Article Versions Notes

Armandi A, Rosso C, Nicolosi A, Caviglia GP, Abate ML, Olivero A, D’Amato D, Vernero M, Gaggini M, Saracco GM, et al. Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine. 2022; 11(3):635. https://doi.org/10.3390/jcm11030635

Armandi, Angelo, Chiara Rosso, Aurora Nicolosi, Gian Paolo Caviglia, Maria Lorena Abate, Antonella Olivero, Daphne D’Amato, Marta Vernero, Melania Gaggini, Giorgio Maria Saracco, and et al. 2022. "Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease" Journal of Clinical Medicine 11, no. 3: 635. https://doi.org/10.3390/jcm11030635

Armandi, A., Rosso, C., Nicolosi, A., Caviglia, G. P., Abate, M. L., Olivero, A., D’Amato, D., Vernero, M., Gaggini, M., Saracco, G. M., Ribaldone, D. G., Leeming, D. J., Gastaldelli, A., & Bugianesi, E. (2022). Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine, 11(3), 635. https://doi.org/10.3390/jcm11030635